BackAmerican Funds 2050 Target Date Retirement Fund Overview

American Funds 2050 Target Date Retirement Fund Other Current Liabilities

Latest other current liabilities for RBHEX: $76B.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$76.05B
↑ 8.04% YoYΔ $5.66B vs prior year quarter

Peer trimmed avg / median

Loading

American Funds 2050 Target Date Retirement Fund Other Current Liabilities History

Loading

American Funds 2050 Target Date Retirement Fund vs. peers: Other Current Liabilities Comparison

Loading

American Funds 2050 Target Date Retirement Fund Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

American Funds 2050 Target Date Retirement Fund (RBHEX) FAQ

As of the most recent data (March 2024), RBHEX shows a other current liabilities of $76B. That compares with $70B in the prior-year period — up 8.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RBHEX's other current liabilities is now $76B (was $70B) — a 8.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether American Funds 2050 Target Date Retirement Fund is outperforming or lagging.

Tracking RBHEX's other current liabilities over time shows whether American Funds 2050 Target Date Retirement Fund is scaling, shrinking, or reshaping that part of the business. The current reading is $76B That compares with $70B in the prior-year period — up 8.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has American Funds 2050 Target Date Retirement Fund's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $76B) with ownership activity and broader fundamentals.